Journals / Eurasian Journal of Medical Investigation / 2019 / Cilt: 3 - Sayı: 3

Etiological Investigation of Patients Visiting a Hematology Polyclinic for Anemia

Pages
173–181
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For health interpretations, extensive screenings and etiologicalstudies should be performed in anemic patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Per the World Health Organization, anemia is defied as a hemoglobin level below 13 g/dL in men, below12 g/dL in nonpregnant women, and below 11 g/dL in pregnant women.
📊
Key Findings & Data:Information on patients who visited to ourhematology polyclinic with anemia between September 2014 and March 2015 was retrospectively reviewed, and 103patients were included in the study.Methods: Anemia was classifid into three groups: nutritional anemia and anemia due to production inadequacy ingroup I; anemia due to increase in erythrocyte destruction in group II; and anemia due to bone marrow infitratingdiseases and hematological malignancies in group III.
💡
Conclusion & Impact:For health interpretations, extensive screenings and etiologicalstudies should be performed in anemic patients
🔬Design:Review & Systematic Survey
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Per the World Health Organization, anemia is defied as a hemoglobin level below 13 g/dL in men, below12 g/dL in nonpregnant women, and below 11 g/dL in pregnant women. Information on patients who visited to ourhematology polyclinic with anemia between September 2014 and March 2015 was retrospectively reviewed, and 103patients were included in the study.Methods: Anemia was classifid into three groups: nutritional anemia and anemia due to production inadequacy ingroup I; anemia due to increase in erythrocyte destruction in group II; and anemia due to bone marrow infitratingdiseases and hematological malignancies in group III. NCSS 2007 & PASS 2008 statistical software programs were usedfor statistical analysis. Kruskal-Wallis and Mann-Whitney U test for quantitative data and tests of Pearson chi-square andFisher-Freeman-Halton tests for qualitative data were used for analysis.Results: The mean ages of groups I, II and III were 47.7, 47.5, and 63.3 years, respectively. Additionally, the mean ageof group III was signifiantly higher. HT and DM were present as additional comorbidities in 20% and 35% of anemiacases, respectively. Although the DM ratio was higher in groups I and II, it was notable that all diabetic patients in groupIII had a diagnosis of MM. There was a statistically signifiant diffrence between (median) PLT levels between groups Iand III. The mean LDH level in group II, measured as 573.8 U/ml, was found to be higher than that in the other groups.Mean sedimentation rates were detected in groups I, II and III as 40.7 mm/h, 56.43 mm/h and 73.6 mm/h, respectively.Conclusion: Because nutritional anemia was followed by physicians in internal medicine, nutritional anemia was seenat a lower rate in our study than in prevalence studies. For health interpretations, extensive screenings and etiologicalstudies should be performed in anemic patients

🔖

Cite This Article

ERKEK, E. T., GÜLTÜRK, E., ALİUSTAOĞLU, M., ESEN, H. Ç. (2022). Etiological Investigation of Patients Visiting a Hematology Polyclinic for Anemia. Eurasian Journal of Medical Investigation, Cilt: 3 - Sayı: 3, 173–181. https://ajindex.com/articles/508723

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Black MM. Micronutrient defiiencies and cognitive functioning. J Nutr 2003;133:3927:31. [CrossRef] 2. Worldwide prevalence of anaemia 1993–2005 WHO Global Database on Anaemia. Editors Bruno de Benoist, Erin McLean, Ines Egli, Mary Cogswell. 2008
  2. Geneva, Switzerland. 3. Fauci AS, Kasper LD, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al eds. Harrison’s Principles of Internal Medicine, 17th ed. McGraw-Hill 2008:96–120. 4. Zafer B. Anemili Hastada Ayırıcı Tanı Rehberi. İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri Anemiler Sempozyumu; 2001:19-20 Nisan; İstanbul, Türkiye; 2001. s. 107–116. 5. Dilek İ, Erkoç R, Sayarlıoğlu M, et al. Van ili merkez ve kırsal kesimde yaşayan sağlıklı erişkin bireylerde hemogram ve ferritin düzeyleri. Van Tıp Dergisi 2002;9:52–55. 6. R. Memişoğulları, H. Demirin,T. Uçgun, et al. Batı Karadeniz Bölgesinde yaşayan Türk erişkinlerindedemir, ferritin, B12 vitamini ve folat gibi anemiparametrelerinin referans aralıkları uygun mudur?Türk Biyokimya Dergisi [Turkish Journal of Biochemistry–Turk J Biochem] 2012;37:4;356–61. [CrossRef] 7. İ. Çetin, Y. Bulut, B. Yıldırım, et al. The Investigation of Some Hematological Valuesand Anemia Prevalence in Adult Populationof Tokat Province, International Journal of Hematology and Oncology Sayı/ Number: 3 Cilt / Volume: 19 Yıl / Year: 2009. 8. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med 2004; 351:1860–73. Multipl myelom tanı ve tedavi kılavuzu 2. Basım 2013, THD. [CrossRef] 9. Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood 2008;112:45–52. [CrossRef] 10. Estey E, Döhne H. Acute myeloid leukemia. Lancet 2006;368:1894–907. [CrossRef] 11. Sallan SE. Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2006; 128-32. leukemia. Hematology Am Soc Hematol Educ Program 2006;128–32. [CrossRef] 12. Artz AS, Thirman MJ. Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic. J Gerontol A Biol Sci Med Sci 2011;66:925–32. [CrossRef] 13. Gunter EW, Lewis BG, Koncikowski SM. (1996): Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994.
  3. Hyattsville, MD: Centers for Disease Control and Prevention. 14. Baltierra